ArriVent shareholders elect Yao and Peterson to board, ratify PwC as auditor

ArriVent BioPharma, Inc.

Quorum of 73.89% (25.2M shares) present at June 18 annual meeting.
Zhengbin Yao elected with 22.1M for vs 0.4M withheld; broker non-votes 2.6M.
Kristine Peterson elected with 21.9M for vs 0.6M withheld; broker non-votes 2.6M.
Ratification of PwC as FY2025 auditor: 25.0M for, 242 against, 167.5K abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.